KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 87 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $50 | -61.2% | 27,840 | -15.8% | 0.00% | -100.0% |
Q1 2023 | $129 | +33.0% | 33,054 | +15.6% | 0.00% | 0.0% |
Q4 2022 | $97 | -99.9% | 28,597 | +22.4% | 0.00% | 0.0% |
Q3 2022 | $128,000 | +161.2% | 23,373 | +115.3% | 0.00% | – |
Q2 2022 | $49,000 | -52.4% | 10,857 | -22.3% | 0.00% | -100.0% |
Q1 2022 | $103,000 | +22.6% | 13,977 | +6.6% | 0.00% | – |
Q4 2021 | $84,000 | -27.0% | 13,107 | +9.0% | 0.00% | -100.0% |
Q4 2017 | $115,000 | +475.0% | 12,030 | +300.2% | 0.00% | – |
Q2 2016 | $20,000 | -4.8% | 3,006 | +24.8% | 0.00% | – |
Q1 2016 | $21,000 | -16.0% | 2,408 | +29.3% | 0.00% | – |
Q4 2015 | $25,000 | 0.0% | 1,863 | -22.7% | 0.00% | – |
Q3 2015 | $25,000 | +19.0% | 2,411 | +216.0% | 0.00% | – |
Q2 2015 | $21,000 | +16.7% | 763 | +28.5% | 0.00% | – |
Q1 2015 | $18,000 | +12.5% | 594 | +37.8% | 0.00% | – |
Q4 2014 | $16,000 | -15.8% | 431 | -21.6% | 0.00% | – |
Q3 2014 | $19,000 | +46.2% | 550 | +95.7% | 0.00% | – |
Q2 2014 | $13,000 | – | 281 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |